명인제약: directors' dealings · South Korea · DART (FSS)

Explore the full management transaction log of 명인제약, a listed issuer based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Market capitalisation: €1,005.9bn. The latest transaction was reported on 6 April 2026 — Mixed. Among the most active insiders: 이동철. All data is free.